The use of aspirin in patients suffering from COVID-19 disease

Aspirin, in moderately higher doses, can be considered with close monitoring for COVID-19 as this is a relatively inexpensive and a promising therapeutic alternative to save lives.

A case report of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 in Maha Sarakham, Thailand

We report a case of a 19-year-old female with multisystemic inflammatory syndrome that was associated with the novel coronavirs disease 2019 (COVID-19), which manifested as serious illness that occurred four weeks after COVID-19 infection. Her clinical manifestations involved multiple organ systems including high-grade fever with shock syndrome, pulmonary edema, myopericarditis with pericardial effusion, hepatitis, generalized maculopapular rash, and several elevated inflammatory markers. She was treated with human immunoglobulin, methylprednisolone, acetylsalicylic acid, enoxaparin, and empirical antibiotics. She required a 2-week hospitalization and was discharged after improvement of clinical symptoms and normalization of inflammatory markers. A day prior to discharge, an echocardiography was done and it showed normal ventricular function and no coronary aneurysmal dilation.